Submission Details
| 510(k) Number | K243746 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 05, 2024 |
| Decision Date | March 12, 2025 |
| Days to Decision | 97 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K243746 is an FDA 510(k) clearance for the Delphi Amplifier, a Amplifier, Physiological Signal (Class II — Special Controls, product code GWL), submitted by Quantalx Neroscience (Kfar Sava, IL). The FDA issued a Cleared decision on March 12, 2025, 97 days after receiving the submission on December 5, 2024. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1835.
| 510(k) Number | K243746 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 05, 2024 |
| Decision Date | March 12, 2025 |
| Days to Decision | 97 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GWL — Amplifier, Physiological Signal |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1835 |